复方玄驹胶囊治疗勃起功能障碍的疗效观察

祖国医学认为，蚂蚁是一种温和的滋补药，具有扶正固本、补肾壮阳、养血荣筋、祛淤通络等功效，其中以补肾之功效最为显著，为此，我们使用其复方制剂复方玄驹胶囊治疗了一组勃起功能障碍（ED）患者，现将治疗情况报告如下。     

勃起功能障碍患者夜间阴茎勃起监测的临床分析

近年来国内外越来越多的采用夜间阴茎勃起现象(NPT)监测,作为勃起功能障碍(ED)临床诊断的一个重要手段.我院采用YJZ-204A型阳痿检测仪对108例ED患者进行监测,其结果如下.     

复方玄驹胶囊对慢性前列腺炎合并勃起功能障碍的疗效观察

目的:观察复方玄驹胶囊对慢性前列腺炎合并勃起功能障碍(ED)的治疗效果及安全性。方法:132例慢性前列腺炎伴发ED患者,治疗前行NIH慢性前列腺炎症状评分(NIH-CPSI)及国际勃起功能指数问卷5(IIEF-5)评分。根据治疗方式不同,将患者分为对照组(70例)及治疗组(62例)。对照组使用左氧氟沙星0.2 g,口服,2/d,连续服用4～6周,及特拉唑嗪2 mg,口服,1/晚,连续服用2个月。治疗组在上述治疗的基础上,同时使用复方玄驹胶囊2粒,口服,3/d,连续服用2个月。结果:所有患者均无严重不良反应出现,能坚持服药。治疗后2个月重新评分,对照组NIH-CPSI平均(16.5±5.9)分,较治疗前(25.1±5.5)分显著改善(P<0.05),IIEF-5平均(13.1±5.2)分,较治疗前(11.3±4.5)分有所增加,但差异无显著性(P>0.05);治疗组NIH-CPSI平均(13.4±5.7)分,IIEF-5平均(17.5±6.5)分,与治疗前比较,均改善显著(P<0.05)。对照组ED总有效率为20%,治疗组ED总有效率为74.2%,其差异有显著性(P<0.05)。结论:复方玄驹胶囊治疗慢性前列腺炎伴发ED,既可明显改善慢性前列腺炎症状,同时,对伴发的ED也有较好的疗效,无严重不良反应,值得推广使用。     

复方玄驹胶囊治疗伴勃起功能障碍的慢性前列腺炎疗效观察

慢性前列腺炎(chronic postatitis,CP)是泌尿男科常见病、多发病.占男科疾病的56%以上[1],而其中青壮年占70%以上[2],且呈逐年上升趋势.其病因复杂[3],可分为急性细菌性前列腺炎、慢性细菌性前列腺炎、非细菌性前列腺炎和前列腺痛4种,其症状表现复杂,除了疼痛及排尿症状之外,无确定病因的性功能障碍尤其是勃起功能障碍(erectile dysfunction,ED)是CP患者常抱怨的问题,具有病情顽固、容易复发、疗效欠佳等特点,严重危害患者身心健康,甚至影响日常工作.     

勃起功能障碍患者行夜间阴茎勃起监测的护理

目的 探讨提高夜间阴茎勃起(NPT)监测结果准确性的护理措施.方法 应用夜间阴茎勃起监测仪对183例勃起功能障碍(ED)患者进行NPT监测.结果 183例患者中,包茎1例、阴茎过分短小2例未完成监测,完成监测的180例中,96例为心理性ED,84例为器质性ED;7例器质性ED患者在皮肤准备及粘贴电极时有明显的勃起反应,但NPT监测夜间未见明显勃起反应.结论 电极粘贴牢固、电极导线连接良好、记录仪电池电量充足、睡眠质量好是保证NPT监测结果准确的关键.     

夜间阴茎勃起试验在勃起功能障碍诊断中的应用

勃起功能障碍(erectile dysfunction,ED)常见于男性尤其是中、老年男性.根据病因将其分为器质性ED(动脉性、静脉性、神经性和内分泌性等)、心理性ED及混合性ED(器质性病因和心理因素同时存在)3种类型.ED的诊断除了详细的病史资料、体格检查和一般实验室检查之外,部分患者必须通过一种或者多种特殊检查才能最后确诊.随着对阴     

复方玄驹胶囊联合盐酸阿朴吗啡治疗勃起功能障碍的临床研究

目的:观察复方玄驹胶囊联合盐酸阿朴吗啡治疗阴茎勃起功能障碍(ED)的疗效。方法:采用复方玄驹胶囊联合盐酸阿朴吗啡治疗115例ED患者为治疗组,单用盐酸阿朴吗啡治疗111例作为对照组,经连续2个月的治疗后,观察两组的国际勃起功能问卷(IIEF-5)的评分改变情况。结果:治疗组与对照组IIEF-5的评分在治疗前分别为(11.42±2.38)、(11.56±2.65)分,两组比较差异无显著性(P>0.05);治疗后分别为(17.85±2.68)、(13.96±3.25)分,均有明显提高(P<0.01),而治疗组在治疗后的评分明显高于对照组(P<0.01);治疗组的显效率、有效率和总有效率均高于对照组。结论:复方玄驹胶囊联合盐酸阿朴吗啡治疗ED有较好疗效,值得临床推广使用。     

复方玄驹胶囊联合山海丹颗粒治疗勃起功能障碍临床疗效观察

目的观察复方玄驹胶囊联合山海丹颗粒治疗勃起功能障碍。方法选择广西中医药大学第一附属医院仁爱分院男科门诊确诊为勃起功能障碍伴高脂血症患者30例,采用复方玄驹胶囊(口服,3粒/次,3次/天)和山海丹颗粒(1袋/次,3次/天),4周为一个疗程,服用三个疗程,采用自身前后对照的方法,根据服药前后各项指标的变化情况评价疗效。结果用药三个疗程后,患者IIEF-5评分显著性升高,患者总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)表达水平均降低,高密度脂蛋白(HDL-C)升高。结论复方玄驹胶囊联合山海丹颗粒可以改善高血脂症患者的勃起功能,同时降低血脂,效果显著,值得临床推广使用。     

夜间阴茎勃起测定系统筛选勃起功能障碍病人的临床应用

目的 :探讨应用尼娃牌 (NEVA)夜间阴茎勃起测定系统筛选勃起功能障碍 (ED)的可行性及意义。　方法 :2 0例门诊ED病人 ,睡前正确粘贴NEVA测定仪电极 ,带机过夜 ,次日数据回放输入主机分析。　结果 :全部病人均可耐受测定 ,依从性好 ,15例病人资料提示阴茎无器质性疾病 ,4例提示阴茎动脉供血不足 ,1例可疑阴茎静脉漏 ,3种病例勃起事件分别为 ( 4 .0± 0 .4 )、( 3 .2± 0 .3 )、( 2 .0± 0 )次 ,阴茎截面积最大改变量分别为( 0 .178± 0 .0 18)、( 0 .0 80± 0 .0 0 4 )、( 0 .13 5± 0 )cm2 ,平均勃起状态阴茎血容量分别为基准水平的 ( 2 2 5 .5± 12 .0 ) %、( 14 5 .2± 10 .6) %、( 12 8.0± 0 ) %。　结论 :尼娃牌夜间阴茎勃起测定系统操作简便、易行、无创伤 ,可区分心理性、血管性ED。     

复方玄驹胶囊联合万艾可治疗万艾可渐进性失效勃起功能障碍的临床观察

目的:探讨复方玄驹胶囊联合万艾可治疗万艾可渐进性失效勃起功能障碍(ED)的临床疗效。方法:将符合万艾可渐进性失效ED诊断标准的36例患者随机分成两组,每组各18例。其中治疗组给予复方玄驹胶囊(口服,2粒/次,3次/日)和万艾可50 mg(性生活前1 h口服)口服;对照组单纯口服万艾可100 mg(性生活前1 h口服)。两组性生活频率1～2次/周,观察期2个月,对用药前后患者国际勃起功能评分(IIEF-5)及TSS伴侣评分进行对比分析。结果:两组每次使用万艾可对勃起功能改善的有效率比较,治疗组总有效率94.44%,对照组88.89%,两组对比差异无显著性意义(P>0.05)。IIEF-5评分治疗组治疗前后分别为(13.166 7±3.601 5)和(20.888 9±3.833 1),而对照组治疗前后分别为(13.055 6±2775 4)和(18.777 8±4.008 2),每组治疗前后对比差异有显著性意义(P<0.05);治疗后两组IIEF-5评分及TSS伴侣评分比较,治疗组的效果均比对照组好,且差异具有显著性意义(P<0.05)。结论:复方玄驹胶囊联合万艾可治疗万艾可渐进性失效ED疗效显著。     

非性交勃起在勃起功能障碍患者阴茎康复中的应用

勃起功能障碍(ED)是临床上常见的一种男科疾病,有研究显示40~70岁的男性ED患病率约52%,且日益趋向年轻化。目前认为,缺氧是ED的独立危险因素,其导致ED的机制复杂多样。近年来,阴茎康复理念备受重视,这一理念的引导实施是通过增加海绵体组织氧供,降低组织纤维化和凋亡以促进勃起功能恢复正常。而针对增加海绵体组织氧供的一些非性交勃起手段,如行为治疗、药物治疗、真空负压吸引装置治疗、海绵体内注射治疗等,可在一定程度上模拟男性正常自然性交勃起,帮助患者进行有效的阴茎康复锻炼。本文就目前非性交勃起治疗在阴茎康复中的应用作一论述。     

Physiology of penile erection and pathophysiology of erectile dysfunction

This article reviews the physiology of penile erection, the components of erectile function, and the pathophysiology of erectile dysfunction. The molecular and clinical under-standing of erectile function continues to gain ground at a particularly fast rate.Advances in gene discovery have aided greatly in working knowledge of smooth muscle relaxation/contraction pathways. The understanding of the nitric oxide pathway has aided not only in the molecular understanding of the tumescence but also greatly in the therapy of erectile dysfunction.     

多导睡眠仪监测下夜间阴茎勃起(NPT) 测定的应用价值

目的探讨多导睡眠仪监测下夜间阴茎勃起(NPT)测定在男性勃起功能障碍(ED)诊断中的作用及意义.方法我们将ED患者随机分成两组各60例、75例分别行多导睡眠仪监测下NPT和普通NPT检查,采用尼娃(NEVA)夜间阴茎勃起测定系统,以阴茎勃起幅度、勃起次数、勃起持续时间等作为评定指标.结果阴茎勃起幅度睡眠监测组为304.90±99.79,普通组为188.43±86.62,两组间存在显著差异(P＜0.01),两组的勃起次数、勃起持续时间也有差异(P＜0.05).结论多导睡眠仪监测下NPT测定具有准确掌握患者睡眠质量,检查数据误差小的优点,尤其对一些病情与诊断不符,怀疑普通NPT检查有假性结果的特殊病例,有较大的应用价值.     

男子勃起功能障碍病人阴茎微循环检测

检测26例勃起功能障碍（ED）病人的阴茎微循环，与17例健康志愿者进行比较，器质性ED病人阴茎头微血管密度为271±5．2，健康者为47．8±6．2（P＜0．01）；异常微血管百分率则分别为32．1±3．4与12．8±1．3（P＜0．01）；心理性ED病人该两项指标与对照组相比没有统计学差异（血管密度47．2±6.8vs47．8±6．2．P＞0．05；异常血管百分率13．1±1．1vs12．8±1．3．P＞0．05）。以上结果揭示，阴茎头微循环障碍与ED病人的器质性改变有关，可用于器质性ED的辅助诊断。     

阴茎微循环检测在阳痿诊断中的价值

目的：探讨阴茎头微循环检测在阳痿诊断中的意义。方法：检测２２例勃起功能障碍病人的阴茎微循环,与１７例健康志愿者进行比较。结果：血管性阳痿病人阴茎头微血管密度（２６．８±６．３ｖｓ４７．８±６．２,Ｐ＜０．０１）和异常微血管百分率（３３．２±３．６ｖｓ１２．８±１．３,Ｐ＜０．０１）与对照组相比有显著性差异;心理性阳痿病人的两项指标（微血管密度４７．２±６．８ｖｓ４７．８±６．２,Ｐ＞０．０５;异常微血管百分率１３．１±１．１ｖｓ１２．８±１．３,Ｐ＞０．０５）与对照组相比没有统计学差异。结论：阴茎头微循环障碍与阳痿病人的器质性改变有关,阴茎头微循环检测可用于血管性阳痿的辅助诊断。     

Sildenafil citrate significantly improves nocturnal penile erections in sildenafil non-responding patients with psychogenic erectile dysfunction

Effects of sildenafil citrate on nocturnal penile tumescence and rigidity (NPTR) were evaluated among sildenafil non-responding patients with psychogenic erectile dysfunction. All patients (n=30), equally divided into groups I and II, completed four consecutive nights using the RigiScan Plus device. Sildenafil citrate (50 mg) was given in the third night in group I and in the fourth in group II, whereas a placebo was given in the remaining nights. Additional patients (n=12) receiving only a placebo served as a control group. Results of NPTR recordings revealed neither significant differences between the control and non-sildenafil nights of both test groups, nor between the corresponding values of both groups (P>0.05). On the other hand, when sildenafil citrate nights of groups I and II taken together were compared with placebo nights, a significant increase of total events duration (P<0.001), average rigidity of the tip (P<0.05) and base (P<0.01), and rigidity activity unit (RAU) and tumescence activity unit (TAU) of tip and base (P<0.001) was observed. These results suggest that performance anxiety may be responsible for failure of response during awakening.     

Infusion pharmacocavernosometry and nocturnal penile tumescence findings in men with erectile dysfunction

Infusion pharmacocavernosometry and nocturnal penile tumescence findings were compared in 50 men with erectile dysfunction of either organic or psychogenic etiology. Of the men 29 had abnormal and 21 had normal nocturnal penile tumescence. Infusion pharmacocavernosometry parameters (equilibrium pressure, maintenance flow rate and 30-second pressure fall) were compared to nocturnal penile tumescence status (normal versus abnormal). When traditional normal values were used for infusion pharmacocavernosometry parameters poor correlation with nocturnal penile tumescence status was found. When new cutpoints for infusion pharmacocavernosometry parameters were chosen a stronger correlation was noted. This study suggests that when vasoactive drugs are injected intracavernously for diagnostic purposes, anxiety and/or the absence of sexual stimulation following the injection may prevent complete cavernous smooth muscle relaxation resulting in falsely abnormal values. Therefore, over reliance on infusion pharmacocavernosometry as a single test for evaluation and treatment decisions concerning erectile dysfunction should be avoided.     

Comparison of nocturnal penile tumescence monitoring and cavernosal smooth muscle content in patients with erectile dysfunction

Purpose: Nocturnal penile tumescence monitoring was compared to cavernosal smooth muscle content in 48 cases of erectile dysfunction.Materials and methods: Pre-operatively nocturnal penile tumescence rigidity (NPTR) testing, colour Doppler sonography and if needed pharmaco cavernosometry-cavernosography were evaluated in 48 impotent patients before surgical intervention. The 40 patients whom all those diagnostic tools were abnormal constituted the first group. In the remaining 8 patients, which constitutes the second group, NPTR testing were normal but the other tests were abnormal. 10 potent patients with congenital penile curvature constituted the third group. Cavernous biopsies were obtained during the surgery and biopsies stained immunohistochemically to quantify smooth muscle cells (SMC) by anti-desmin and anti-SMA.Results: We observed statistical significant difference of corporeal SMC content with regard to first Vs second group and first Vs third group (p < 0.05). However we did not observe statistically significant difference with regard to second vs third group (p > 0.05).Conclusion: NPTR testing appears to correlate well with corporeal SMC, which is the key structures of erection. We think that with taking into the consideration of its specific reservations, NPTR testing is still one of the best non-invasive tool in the differential diagnosis of erectile dysfunction.     

夜间阴茎胀大试验在勃起功能障碍诊断中的应用

ED是一种常见的男科疾病,常由神经、血管或心理因素引起。其诊断方式多样。RigiScan阴茎硬度测量是以检测阴茎勃起为主的客观评估方法,近年来较为广泛的被临床所采用。本文综述了6项RigiScan检测参数(阴茎勃起次数、阴茎勃起总持续时间、阴茎头部和根部胀大硬度、阴茎头部和根部肿胀度以及周径胀大活力单位和硬度活力单位在ED诊断中的应用价值,以期为临床医师及科研人员应用夜间阴茎胀大试验(NPT)提供帮助。